SNYDER DAVID S
SEC insider (Form 3/4/5 filer). CIK 0001398625. Chief Financial Officer at Coya Therapeutics, Inc. (COYA). 3 reported Form 4/5 transactions since Sep 2024; latest on Jan 22, 2026. Located in HOUSTON, TX.
Companies SNYDER DAVID S has filed insider reports for
- Coya Therapeutics, Inc. (COYA): Officer, Chief Financial Officer
SNYDER DAVID S
CIK: 0001398625
Transaction Breakdown
Open Market Buys (P)1 (33.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
COYA
Coya Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jan 22, 2026COYA
Coya Therapeutics, Inc.
AwardDirectStock Option (right to buy)
140K shares- - Jan 9, 2025COYA
Coya Therapeutics, Inc.
AwardDirectStock Option (right to buy)
140.6K shares- - Nov 14, 2024COYA
Coya Therapeutics, Inc.
PurchaseDirect1.8K shares at avg. $7.19$13K
1-3 of 3 transactions